| 2008 |
LUZP1 (LUZP) deficiency in knockout mice causes cranial neural tube closure defect (NTD) with ectopic Sonic Hedgehog expression and elevated apoptosis in the dorsal lateral neuroepithelium of the hindbrain, establishing a role for LUZP1 in neural tube closure during brain development. |
Knockout mouse (Luzp-KO/lacZ-KI), lacZ reporter expression, immunohistochemistry for Sonic Hedgehog, TUNEL assay for apoptosis |
Biochemical and biophysical research communications |
Medium |
18801334
|
| 2020 |
LUZP1 localizes around centrioles and to actin cytoskeleton; loss of LUZP1 reduces F-actin levels, facilitates ciliogenesis, and alters Sonic Hedgehog signaling; truncated SALL1 (causative in Townes-Brocks Syndrome) increases ubiquitin proteasome-mediated degradation of LUZP1. LUZP1 was identified as an interactor of truncated SALL1 by TurboID proximity labeling and pulldowns, and associates with centrosome and actin filament factors. |
TurboID proximity labeling, pulldown assays, immunofluorescence localization, LUZP1 loss-of-function (siRNA/CRISPR), F-actin measurement, ciliogenesis assay, Sonic Hedgehog signaling reporter, ubiquitin-proteasome inhibitor rescue |
eLife |
High |
32553112
|
| 2020 |
LUZP1 is an actin-stabilizing protein that localizes to actin filaments and the centrosome/basal body; its depletion increases MyosinVa at the centrosome and promotes primary cilia formation. LUZP1 regulates actin dynamics by mobilizing ARP2 to centrosomes and interacts with EPLIN as well as known ciliogenesis and cilia-length regulators. |
siRNA depletion, immunofluorescence localization, ciliogenesis assay, actin dynamics assays, co-immunoprecipitation/proximity labeling for LUZP1-EPLIN and ARP2 interactions, centrosome ARP2 recruitment assay |
The Journal of cell biology |
High |
32496561
|
| 2020 |
LUZP1 is a microtubule-associated protein that localizes to tight junction (TJ)-associated circumferential actomyosin rings but not adherens junction rings. Di-phosphorylated myosin light chain (ppMLC) promotes LUZP1 recruitment to TJ-associated rings, where LUZP1 inhibits myosin phosphatase in a microtubule-facilitated manner, sustaining ppMLC levels and driving epithelial cell apical constriction. |
Unbiased screening of microtubule-associated proteins in AJC-enriched fraction, immunofluorescence localization, LUZP1 knockout, ppMLC quantification, myosin phosphatase activity assays, epistasis/rescue assays |
The EMBO journal |
High |
33346378
|
| 2021 |
CRISPR/Cas9-mediated loss of Luzp1 in mouse fibroblasts promotes cell migration and invasion, reduces cell viability, increases apoptosis, increases centriole numbers and nuclear size, and alters ACTR3/ARP3 and phospho-cofilin ratios, implicating LUZP1 in the regulation of actin polymerization beyond filament bundling. |
CRISPR/Cas9 knockout, cell migration and invasion assays, viability/apoptosis assays, immunofluorescence for centriole number/nuclear size, Western blot for ARP3 and phospho-cofilin |
Frontiers in cell and developmental biology |
Medium |
33869174
|
| 2021 |
LUZP1 is a component of the CECR2-containing chromatin remodeling factor (CERF) complex in embryonic stem (ES) cells but not in the testis, indicating tissue-specific complex composition. LUZP1 appears to stabilize the CERF complex in ES cells. |
Co-immunoprecipitation, mass spectrometry identification of CERF complex components in ES cells and testis |
Biochemistry and cell biology |
Medium |
34197713
|
| 2023 |
LUZP1 colocalizes with the chromosomal passenger complex (CPC) at the centromere in metaphase and at the central spindle in anaphase, with these localizations regulated by CPC activity and KIF20A. LUZP1 interacts with DAPK3 (death-associated protein kinase 3) and MYL9 (myosin light chain 9), and inhibits MYL9 phosphorylation by DAPK3. Loss of LUZP1 accelerates contractile ring constriction velocity during cytokinesis. |
siRNA knockdown, time-lapse imaging of cytokinesis, mass spectrometry, co-immunoprecipitation, immunofluorescence localization, CPC inhibitor treatment, kinase activity assay for DAPK3-MYL9 phosphorylation |
The FEBS journal |
High |
38009294
|
| 2024 |
LUZP1 plays a central role in the maturation of thick contractile actomyosin bundles; its knockout results in defective concatenation and persistent association of myosin II filaments, impairing myosin II stack assembly and thick ventral stress fiber formation, leading to abnormal cell morphogenesis, migration, and force generation. |
LUZP1 knockout, live-cell imaging of myosin II filament dynamics, immunofluorescence, traction force microscopy, cell morphology and migration assays |
Cellular and molecular life sciences |
Medium |
38832964
|
| 2025 |
LUZP1 localizes to actin in CaMKIIα-expressing hippocampal dentate gyrus neurons; its depletion impedes dendritic spine maturation (excess filopodia, loss of mushroom spines) in vitro and in vivo, reduces spontaneous electrical activity and synaptic plasticity. Mechanistically, LUZP1 directly interacts with filamin A and modulates the Rac1-PAK1 signaling pathway to control dendritic maturation. Conditional deletion in CaMKIIα neurons impairs learning and memory. |
Conditional LUZP1 knockout (CaMKIIα-Cre), shRNA knockdown in vitro and in vivo, immunofluorescence localization, dendritic spine morphology analysis, electrophysiology (spontaneous activity, LTP), co-immunoprecipitation with filamin A, Rac1-PAK1 activity assay, behavioral learning/memory tests |
The Journal of neuroscience |
High |
40180573
|
| 2026 |
The E3 ubiquitin ligase COP1 ubiquitinates and degrades LUZP1, thereby releasing DAPK3 from LUZP1-mediated suppression and leading to enhanced MYL9 phosphorylation, EMT activation, and JAK2-STAT3-CCND2 signaling, promoting colorectal cancer liver metastasis and oxaliplatin resistance. |
In vitro and in vivo functional experiments, multi-omics analysis of patient-derived organoids, ubiquitination assay, co-immunoprecipitation, kinase activity assay, EMT and signaling pathway readouts |
Experimental hematology & oncology |
Medium |
41937206
|
| 2026 |
NF-κB acts as a key upstream transcriptional regulator of LUZP1 expression: NF-κB inhibition reduces LUZP1 levels, while stimulation with IL-1β or TNF-α induces LUZP1 upregulation and rescues migration defects caused by LUZP1 depletion in head and neck squamous cell carcinoma cells. |
NF-κB inhibitor treatment, cytokine stimulation (IL-1β, TNF-α), LUZP1 knockdown, migration/invasion assays, rescue experiment |
Oncology reports |
Medium |
41952496
|